In the last decade, the utilization of radio technology for a variety of clinical and medical applications has increased dramatically. Advances in microelectronics have enabled the miniaturization and integration of biomedical sensors and radio transceivers into single units. Such wireless sensors can be worn or implanted, and they facilitate the continuous collection and transmission of physiological signals. The centrally coordinated or distributed interconnection of wireless biomedical sensors, referred to as a body area network (BAN), has already been standardized in IEEE Standard 802.15.6-2012. Besides narrowband (NB), IEEE Standard 802.15.6-2012 supports the use of ultrawideband (UWB) radio interfaces for wearable sensors. The U.S. Federal Communications Commission (FCC) defines UWB signals to be those with fractional bandwidth exceeding 20% of the center frequency, or alternatively, a bandwidth greater than 500 MHz. A number of techniques can be used to generate UWB signals; the most widely used is the one referred to as impulse radio (IR) and consists of transmitting very narrow pulses in the time domain, commonly in the order of a few nanoseconds with fast rise times reaching 50 ps [1]. Another common approach to generate UWB signals is subcarrier aggregation in orthogonal frequency-domain multiplexing (OFDM), which is generally used for short-range nonmedical indoor communications. The very large bandwidth enables high-data-rate communications. In the presence of noise and power constraints, UWB allows trading a section of the ?bandwidth for power according to the Shannon?Hartley theorem. This means UWB communication systems can operate with ultralow power and low signal-to-noise ratio (SNR) using different modulation and coding strategies. UWB signals have other inherent characteristics that make them suitable for the wireless interface of wearable biomedical sensors. Noiselike behavior due to the extremely low maximal effective isotropically radiated power (EIRP) spectral density of ?41.3 dBm/MHz makes UWB signals difficult to detect by NB systems and robust against jamming, potentially rescinding the need for complex encryption algorithms. Additionally, UWB signals do not represent a threat to patients? safety [2]. Much research has been done toward the use of BAN technology for ubiquitous monitoring of patients suffering from chronic diseases. Nevertheless, the commercial use of UWB for BAN has been limited in part by the FCC regulations, which restrict the communication applications to 3.1?10.6 GHz where propagation conditions in the body environment are rather unfavorable.
Read full abstract